Trial site
Globe Badania Kliniczne Sp. z o.o.
- 7running trials
- 8closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis6 trials
- Crohn's disease5 trials
- Psoriasis3 trials
- Atopic dermatitis (eczema)1 trial
- Hepatitis C1 trial
- Multiple sclerosis1 trial
- Phase
- Phase 27 trials
- Phase 37 trials
- Phase 11 trial
- Status
- Completed8 trials
- Active, not recruiting4 trials
- Recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Spyre Therapeutics, Inc.2 trials
- Sun Pharmaceutical Industries Limited2 trials
- Takeda2 trials
- Alvotech Swiss AG1 trial
- Atea Pharmaceuticals Inc.1 trial
- and 7 more
Running trials
Not yet recruiting
Enrolling by invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Active, not recruiting
Recruiting
Active, not recruiting
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ulcerative colitis2 recruiting
- Multiple sclerosis1 recruiting
Closed trials
Completed
Completed
Completed
A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
Completed
Completed
To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis
Completed
Completed
Completed
An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026